Trinity Resources Inc. (OTC US:TRRI) is up over 1000% and currently trading at $1.8. TRRI currently trades on the OTC board. Yesterday, TRRI announced that following approval by a super majority of Alzex Biomedical Group Inc. (“Alzex”) shareholders obtained on June 30, 2022, it has now entered into a binding Asset purchase agreement (the “Agreement”) with Alzex whereby it will receive all of the assets and intellectual property (the “Assets”) of Alzex Biomedical.
As per the press release, Alzex has devised an innovative therapeutic approach aimed at treating brain diseases by means of highly selective bio precursor drugs (prodrugs). The validity of this approach is evidenced by the company’s progress on Alzheimer’s Disease. The company has developed and patented two families of this new class of drugs, for which “proof of concept” in animal trials (in-vitro) has been established. This new class of drugs do not deploy any biological activity before they have crossed the blood-brain barrier, and hence do not induce significant side effects. The therapy can then target specific receptor sites in a more selective way, forming a superior delivery system through the blood-brain barrier. The therapy can then target specific receptor sites in a more selective way, forming a superior delivery system through the blood-brain barrier. This technology could potentially be applied to any number of brain diseases.
Other hot stocks for the day include Cooper-Standard Holdings Inc (NYSE:CPS), Pineapple Energy Inc. (NASDAQ:PEGY) and Carvana Co. (NYSE:CVNA)
For consideration of being featured on WallstreetPR, contact: Editor@Wallstreetpr.com